Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;30(24):1867-1879.
doi: 10.2174/0113816128312442240519184440.

Pharmacological Mechanism of Herbal Interventions for Bipolar Disorder

Affiliations
Review

Pharmacological Mechanism of Herbal Interventions for Bipolar Disorder

Abhinav Singh et al. Curr Pharm Des. 2024.

Abstract

Bipolar disorder is a neuropsychiatric disease characterized by an abundance of undesired ideas and thoughts associated with recurrent episodes of mania or hypomania and depression. Alterations in the circuits, including the prefrontal cortex, striatum, and limbic system, regulate mood and cause variation in several crucial neurotransmitters, including serotonin, dopamine, GABA, and glutamate. Imbalances in dopamine levels have been implicated in the manic phase, while variance in serotonin is linked to depressive episodes. The precise pathophysiology of bipolar disorder is still unknown. Though different treatments are available, like lithium, risperidone, valproic acid, etc., which are widely used, they come with certain limitations, including narrow therapeutic index, hypothyroidism, weight gain, extrapyramidal symptoms, etc. The interest in herbal- based treatments for bipolar disorder arises from the desire for alternative, potentially more natural, and holistic approaches with fewer side effects. The current review focuses on the potential effects of herbal drugs and their derivatives to alleviate the symptoms of bipolar disorder.

Keywords: Bipolar disorder; anxiety.; depression; herbal drugs; neurotransmitters; pharmacological mechanisms.

PubMed Disclaimer

Similar articles

References

    1. Vieta E.; Berk M.; Schulze T.G.; Carvalho A.F.; Suppes T.; Calabrese J.R.; Gao K.; Miskowiak K.W.; Grande I.; Bipolar disorders. Nat Rev Dis Primers 2018,4(1),18008 - DOI - PubMed
    1. Wartchow K.M.; Scaini G.; Quevedo J.; Glial-neuronal interaction in synapses: A possible mechanism of the pathophysiology of bipolar disorder. Adv Exp Med Biol 2023,1411,191-208 - DOI - PubMed
    1. Carvalho A.F.; Firth J.; Vieta E.; Bipolar disorder. N Engl J Med 2020,383(1),58-66 - DOI - PubMed
    1. Schiweck C.; Henriquez A.G.; Aichholzer M.; Thanarajah E.S.; Cáceres V.S.; Matura S.; Grimm O.; Haavik J.; Schneider K.S.; Quiroga R.J.A.; Faraone S.V.; Reif A.; Comorbidity of ADHD and adult bipolar disorder: A systematic review and meta-analysis. Neurosci Biobehav Rev 2021,124,100-123 - DOI - PubMed
    1. Wang A.K.; Miller B.J.; Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients: Comparisons between schizophrenia, bipolar disorder, and depression. Schizophr Bull 2018,44(1),75-83 - DOI - PubMed

Substances